Myoung-Ja Park
Overview
Explore the profile of Myoung-Ja Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamato G, Park M, Sotomatsu M, Kaburagi T, Maruyama K, Kobayashi T, et al.
Int J Hematol
. 2021 Jan;
113(5):662-667.
PMID: 33394336
Transient abnormal myelopoiesis (TAM) is a unique clonal myeloproliferation characterized by immature megakaryoblasts that occurs in 5-10% of neonates with Down syndrome (DS). Although TAM regresses spontaneously in most patients,...
2.
Inoue K, Miura H, Hoshino A, Kamiya T, Tanita K, Ohye T, et al.
Transpl Infect Dis
. 2020 May;
22(5):e13331.
PMID: 32424944
Human herpesvirus-6 (HHV-6) is a common pathogen affecting the human population. Primary HHV-6 infection generally occurs during infancy and causes exanthema subitum. Moreover, HHV-6 may exhibit inherited chromosomally integrated HHV-6...
3.
Ohki K, Kiyokawa N, Saito Y, Hirabayashi S, Nakabayashi K, Ichikawa H, et al.
Haematologica
. 2018 Sep;
104(1):128-137.
PMID: 30171027
Fusion genes involving have recently been identified in precursor B-cell acute lymphoblastic leukemia, mutually exclusive of the common risk stratifying genetic abnormalities, although their true incidence and associated clinical characteristics...
4.
Yamato G, Shiba N, Yoshida K, Hara Y, Shiraishi Y, Ohki K, et al.
Blood
. 2018 Mar;
131(20):2266-2270.
PMID: 29540347
No abstract available.
5.
Yamato G, Yamaguchi H, Handa H, Shiba N, Kawamura M, Wakita S, et al.
Genes Chromosomes Cancer
. 2017 Jul;
56(11):800-809.
PMID: 28710806
High PRDM16 (also known as MEL1) expression is a representative marker of acute myeloid leukemia (AML) with NUP98-NSD1 and is a significant predictive marker for poor prognosis in pediatric AML....
6.
Yamato G, Shiba N, Yoshida K, Shiraishi Y, Hara Y, Ohki K, et al.
Genes Chromosomes Cancer
. 2017 Jan;
56(5):382-393.
PMID: 28063196
ASXL2 is an epigenetic regulator involved in polycomb repressive complex regulation or recruitment. Clinical features of pediatric acute myeloid leukemia (AML) patients with ASXL2 mutations remain unclear. Thus, we investigated...
7.
Hara Y, Shiba N, Ohki K, Tabuchi K, Yamato G, Park M, et al.
Genes Chromosomes Cancer
. 2017 Jan;
56(5):394-404.
PMID: 28063190
Pediatric acute megakaryoblastic leukemia in non-Down syndrome (AMKL) is a unique subtype of acute myeloid leukemia (AML). Novel CBFA2T3-GLIS2 and NUP98-KDM5A fusions recurrently found in AMKL were recently reported as...
8.
Shiba N, Yoshida K, Shiraishi Y, Okuno Y, Yamato G, Hara Y, et al.
Br J Haematol
. 2016 Jul;
175(3):476-489.
PMID: 27470916
Acute myeloid leukaemia (AML) is a molecularly and clinically heterogeneous disease. Targeted sequencing efforts have identified several mutations with diagnostic and prognostic values in KIT, NPM1, CEBPA and FLT3 in...
9.
Shiba N, Ohki K, Kobayashi T, Hara Y, Yamato G, Tanoshima R, et al.
Br J Haematol
. 2015 Dec;
172(4):581-91.
PMID: 26684393
Recent reports described the NUP98-NSD1 fusion as an adverse prognostic marker for acute myeloid leukaemia (AML) and PRDM16 (also known as MEL1) as the representative overexpressed gene in patients harbouring...
10.
Sano H, Ohki K, Park M, Shiba N, Hara Y, Sotomatsu M, et al.
Br J Haematol
. 2015 Apr;
170(3):391-7.
PMID: 25858548
Mutations in the colony-stimulating factor 3 receptor (CSF3R) and calreticulin (CALR) genes have been reported in a proportion of adults with myeloproliferative disease. However, little is known about CSF3R or...